Back to search
FDAFDA · Food and drugs·Recall number D-0465-2024

FUL-GLO, Fluorescein Sodium Ophthalmic Strips USP 1 mg, 100 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-404-01.

Published May 1, 2024 · Recall initiated: April 19, 2024

Summary

FDA records drug Class II recall D-0465-2024, published May 1, 2024 and initiated April 19, 2024. Recalling firm: Nomax Inc; Status: Ongoing; Reported quantity: 15,444 cartons; Lot: Lot #: 14776, Exp. 05/31/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nomax Inc
Distributor
Nationwide in the USA
Lot
Lot #: 14776, Exp. 05/31/2024.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was FUL-GLO, Fluorescein Sodium Ophthalmic Strips USP 1 mg, 100 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-404-01. recalled?

Yes. FDA published recall D-0465-2024 on May 1, 2024. Reported hazard: Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

What should I do if I have this product?

Voluntary: Firm initiated